Masimo Stock Price, News & Analysis (NASDAQ:MASI)

$87.90 -0.27 (-0.31 %)
(As of 01/23/2018 04:00 PM ET)
Previous Close$87.90
Today's Range$87.43 - $88.56
52-Week Range$70.48 - $104.71
Volume336,244 shs
Average Volume375,844 shs
Market Capitalization$4.54 billion
P/E Ratio13.93
Dividend YieldN/A
Beta0.72

About Masimo (NASDAQ:MASI)

Masimo logoMasimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:MASI
CUSIP57479510
Phone+1-949-2977000

Debt

Debt-to-Equity RatioN/A
Current Ratio3.17%
Quick Ratio2.59%

Price-To-Earnings

Trailing P/E Ratio13.9302694136292
Forward P/E Ratio29.80
P/E Growth3.39

Sales & Book Value

Annual Sales$694.63 million
Price / Sales6.54
Cash Flow$2.53 per share
Price / Cash34.78
Book Value$11.28 per share
Price / Book7.79

Profitability

Trailing EPS$6.31
Net Income$300.66 million
Net Margins45.83%
Return on Equity22.17%
Return on Assets16.60%

Miscellaneous

Employees1,243
Outstanding Shares51,670,000

Masimo (NASDAQ:MASI) Frequently Asked Questions

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) posted its quarterly earnings results on Tuesday, October, 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the consensus estimate of $0.53 by $0.17. The medical equipment provider earned $193.69 million during the quarter, compared to analysts' expectations of $189.01 million. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The firm's revenue was up 15.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.52 EPS. View Masimo's Earnings History.

When will Masimo make its next earnings announcement?

Masimo is scheduled to release their next quarterly earnings announcement on Monday, February, 12th 2018. View Earnings Estimates for Masimo.

Where is Masimo's stock going? Where will Masimo's stock price be in 2018?

7 Wall Street analysts have issued 12-month target prices for Masimo's shares. Their forecasts range from $60.00 to $112.00. On average, they expect Masimo's stock price to reach $97.00 in the next twelve months. View Analyst Ratings for Masimo.

Who are some of Masimo's key competitors?

Who are Masimo's key executives?

Masimo's management team includes the folowing people:

  • Joseph E. Kiani, Chairman of the Board, Chief Executive Officer (Age 52)
  • Micah Young, Chief Financial Officer, Executive Vice President
  • John Coleman, President - Worldwide Sales, Professional Services and Medical Affairs (Age 53)
  • Rick Fishel, President - Worldwide OEM Business & Strategic Development (Age 59)
  • Anand Sampath, Chief Operating Officer (Age 50)
  • Yongsam Lee, Executive Vice President, Chief Information Officer (Age 52)
  • Tom McClenahan, Executive Vice President, General Counsel, Corporate Secretary (Age 44)
  • Steven J. Barker M.D., Ph.D., Director (Age 72)
  • Sanford Fitch, Independent Director (Age 76)
  • Thomas Harkin, Independent Director (Age 77)

Who owns Masimo stock?

Masimo's stock is owned by a number of of institutional and retail investors. Top institutional investors include Acadian Asset Management LLC (2.04%), Schwab Charles Investment Management Inc. (0.72%), Bank of Montreal Can (0.18%), Texas Permanent School Fund (0.06%), Convergence Investment Partners LLC (0.03%) and Louisiana State Employees Retirement System (0.02%). Company insiders that own Masimo stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

Who sold Masimo stock? Who is selling Masimo stock?

Masimo's stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Convergence Investment Partners LLC, Bank of Montreal Can, Schwab Charles Investment Management Inc., Texas Permanent School Fund, Bowling Portfolio Management LLC, Louisiana State Employees Retirement System and First Citizens Bank & Trust Co.. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo.

Who bought Masimo stock? Who is buying Masimo stock?

Masimo's stock was purchased by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C. and Alpha Windward LLC. View Insider Buying and Selling for Masimo.

How do I buy Masimo stock?

Shares of Masimo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Masimo's stock price today?

One share of Masimo stock can currently be purchased for approximately $87.90.

How big of a company is Masimo?

Masimo has a market capitalization of $4.54 billion and generates $694.63 million in revenue each year. The medical equipment provider earns $300.66 million in net income (profit) each year or $6.31 on an earnings per share basis. Masimo employs 1,243 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 Discovery, IRVINE, CA 92618-3105, United States. The medical equipment provider can be reached via phone at +1-949-2977000 or via email at [email protected]


MarketBeat Community Rating for Masimo (MASI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  187 (Vote Underperform)
Total Votes:  392
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Masimo (NASDAQ:MASI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.572.572.572.43
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $97.00$97.00$97.00$87.40
Price Target Upside: 12.79% upside12.79% upside16.06% upside8.14% downside

Masimo (NASDAQ:MASI) Consensus Price Target History

Price Target History for Masimo (NASDAQ:MASI)

Masimo (NASDAQ:MASI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Stifel NicolausReiterated RatingBuy$108.00N/AView Rating Details
8/14/2017BTIG ResearchUpgradeNeutral -> Buy$100.00MediumView Rating Details
7/19/2017Roth CapitalBoost Price TargetBuy$96.00 -> $105.00LowView Rating Details
5/22/2017WedbushReiterated RatingOutperform$112.00LowView Rating Details
3/16/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralHighView Rating Details
2/13/2017Raymond James FinancialDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017CitigroupDowngradeMarket Perform$60.00N/AView Rating Details
(Data available from 1/23/2016 forward)

Earnings

Masimo (NASDAQ:MASI) Earnings History and Estimates Chart

Earnings by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ MASI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/12/2018$0.56N/AView Earnings Details
10/31/2017Q3 2017$0.53$0.70$189.01 million$193.69 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.71$0.83$189.03 million$192.90 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.60$0.82$184.14 million$186.30 millionViewListenView Earnings Details
2/14/2017Q416$0.52$0.51$180.48 million$183.20 millionViewListenView Earnings Details
11/2/2016Q316$0.42$0.52$165.51 million$167.60 millionViewListenView Earnings Details
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.43$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.27$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.39$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
11/2/2010Q3 2010$0.25$0.27ViewN/AView Earnings Details
8/3/2010Q2 2010$0.25$0.25ViewN/AView Earnings Details
5/4/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/16/2010Q4 2009$0.22$0.23ViewN/AView Earnings Details
11/3/2009Q3 2009$0.21$0.22ViewN/AView Earnings Details
8/4/2009Q2 2009$0.21$0.22ViewN/AView Earnings Details
5/5/2009Q1 2009$0.19$0.22ViewN/AView Earnings Details
3/3/2009Q4 2008$0.18$0.24ViewN/AView Earnings Details
10/27/2008Q3 2008$0.16$0.22ViewN/AView Earnings Details
8/4/2008Q2 2008$0.14$0.18ViewN/AView Earnings Details
4/29/2008Q1 2008$0.11$0.15ViewN/AView Earnings Details
2/26/2008Q4 2007$0.13$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Masimo (NASDAQ:MASI) Earnings Estimates

2018 EPS Consensus Estimate: $2.53
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.63$0.63$0.63
Q2 20181$0.65$0.65$0.65
Q3 20181$0.64$0.64$0.64
Q4 20181$0.61$0.61$0.61
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Masimo (NASDAQ:MASI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Masimo (NASDAQ MASI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 13.10%
Institutional Ownership Percentage: 83.64%
Insider Trades by Quarter for Masimo (NASDAQ:MASI)
Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ MASI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2018Yongsam LeeEVPSell10,000$88.17$881,700.0075,018View SEC Filing  
12/4/2017Yongsam LeeEVPSell18,198$88.85$1,616,892.3070,800View SEC Filing  
12/1/2017Yongsam LeeEVPSell5,900$88.31$521,029.0070,800View SEC Filing  
11/9/2017Yongsam LeeEVPSell13,976$89.43$1,249,873.6874,000View SEC Filing  
11/1/2017Steven BarkerDirectorSell10,000$90.00$900,000.0073,249View SEC Filing  
11/1/2017Yongsam LeeEVPSell5,000$89.89$449,450.0074,000View SEC Filing  
8/17/2017Sanford FitchDirectorSell11,000$87.25$959,750.0072,249View SEC Filing  
7/20/2017Jon ColemanInsiderSell25,000$97.50$2,437,500.0032,201View SEC Filing  
7/14/2017Rick FishelInsiderSell15,000$94.85$1,422,750.0035,022View SEC Filing  
7/13/2017Sanford FitchDirectorSell6,000$91.89$551,340.0089,249View SEC Filing  
7/11/2017Anand SampathCOOSell40,000$92.00$3,680,000.0020,000View SEC Filing  
7/11/2017Rick FishelInsiderSell15,000$92.85$1,392,750.0035,022View SEC Filing  
6/29/2017Sanford FitchDirectorSell14,000$92.06$1,288,840.0090,249View SEC Filing  
5/1/2017Joe E KianiCEOSell145,841$102.37$14,929,743.17165,082View SEC Filing  
4/28/2017Thomas Samuel McclenahanEVPSell8,000$102.75$822,000.002,000View SEC Filing  
4/26/2017Joe E KianiCEOSell154,159$99.70$15,369,652.30219,241View SEC Filing  
4/25/2017Joe E KianiCEOSell13,201$101.00$1,333,301.00219,241View SEC Filing  
4/25/2017Jon ColemanInsiderSell50,000$100.00$5,000,000.0014,682View SEC Filing  
4/25/2017Yongsam LeeEVPSell10,000$100.00$1,000,000.0079,000View SEC Filing  
4/24/2017Joe E KianiCEOSell100,000$99.00$9,900,000.00219,241View SEC Filing  
4/24/2017Thomas Samuel McclenahanEVPSell10,000$98.75$987,500.0010,000View SEC Filing  
4/20/2017Thomas Samuel McclenahanEVPSell10,000$95.75$957,500.004,000View SEC Filing  
4/19/2017Yongsam LeeEVPSell10,000$95.00$950,000.0079,000View SEC Filing  
4/4/2017Raad Mark DeCFOSell48,000$93.25$4,476,000.0014,660View SEC Filing  
3/22/2017Sanford FitchDirectorSell3,000$93.23$279,690.0080,000View SEC Filing  
3/10/2017Paul JansenEVPSell55,611$94.47$5,253,571.1710,000View SEC Filing  
3/9/2017Ramshorst David J VanInsiderSell7,500$94.20$706,500.002,500View SEC Filing  
2/23/2017Raad Mark DeCFOSell30,000$86.25$2,587,500.0017,660View SEC Filing  
2/17/2017Raad Mark DeCFOSell45,000$80.00$3,600,000.0017,660View SEC Filing  
2/16/2017Joe E KianiCEOSell300,000$80.04$24,012,000.00119,241View SEC Filing  
2/3/2017Jon ColemanInsiderSell6,000$75.00$450,000.0013,182View SEC Filing  
2/3/2017Raad Mark DeCFOSell15,000$75.00$1,125,000.0017,660View SEC Filing  
1/27/2017Jon ColemanInsiderSell5,800$72.50$420,500.008,707View SEC Filing  
1/27/2017Raad Mark DeCFOSell15,000$72.50$1,087,500.0017,660View SEC Filing  
1/20/2017Jon ColemanInsiderSell200$72.50$14,500.007,282View SEC Filing  
1/13/2017Yongsam LeeEVPSell10,000$72.00$720,000.0079,000View SEC Filing  
1/10/2017Jon ColemanInsiderSell6,000$70.00$420,000.0013,182View SEC Filing  
1/10/2017Raad Mark DeCFOSell15,000$70.00$1,050,000.0017,660View SEC Filing  
1/10/2017Yongsam LeeEVPSell10,000$70.00$700,000.0079,000View SEC Filing  
1/9/2017Paul JansenEVPSell17,945$68.88$1,236,051.6017,945View SEC Filing  
1/3/2017Ramshorst David J VanInsiderSell4,000$67.20$268,800.005,000View SEC Filing  
12/27/2016Paul JansenEVPSell2,055$68.88$141,548.402,055View SEC Filing  
12/21/2016Jon ColemanInsiderSell4,000$67.50$270,000.004,459View SEC Filing  
12/16/2016Thomas Samuel McclenahanEVPSell10,000$66.00$660,000.0010,000View SEC Filing  
12/8/2016Paul JansenEVPSell10,000$63.88$638,800.005,000View SEC Filing  
12/7/2016Thomas Samuel McclenahanEVPSell2,293$63.00$144,459.004,000View SEC Filing  
12/6/2016Joe E KianiCEOSell52,859$62.03$3,278,843.77119,241View SEC Filing  
12/6/2016Thomas Samuel McclenahanEVPSell4,000$63.00$252,000.004,000View SEC Filing  
12/1/2016Joe E KianiCEOSell36,119$62.06$2,241,545.14119,241View SEC Filing  
11/29/2016Joe E KianiCEOSell104,870$62.27$6,530,254.90119,241View SEC Filing  
11/23/2016Joe E KianiCEOSell85,771$62.06$5,322,948.26119,241View SEC Filing  
11/22/2016Joe E KianiCEOSell869$62.00$53,878.00119,241View SEC Filing  
11/21/2016Joe E KianiCEOSell30,462$62.04$1,889,862.48119,241View SEC Filing  
11/18/2016Joe E KianiCEOSell20,381$62.02$1,264,029.62119,241View SEC Filing  
11/1/2016Anand SampathCOOSell65,000$55.04$3,577,600.0023,171View SEC Filing  
10/31/2016Anand SampathCOOSell51,345$55.05$2,826,542.2523,171View SEC Filing  
10/19/2016Sanford FitchDirectorSell2,000$59.05$118,100.0046,000View SEC Filing  
10/10/2016Joe E KianiCEOSell84,617$60.26$5,099,020.42126,450View SEC Filing  
10/10/2016Yongsam LeeEVPSell30,000$60.50$1,815,000.0093,000View SEC Filing  
10/5/2016Sanford FitchDirectorSell2,000$59.58$119,160.0048,000View SEC Filing  
10/4/2016Joe E KianiCEOSell4,300$60.07$258,301.00121,441View SEC Filing  
10/3/2016Joe E KianiCEOSell2,200$60.00$132,000.00121,441View SEC Filing  
9/30/2016Thomas Samuel McclenahanEVPSell10,000$59.00$590,000.0010,000View SEC Filing  
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64123,705View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12158,911View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.0050,000View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00120,240View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97120,240View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00152,777View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00759View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.0054,000View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.0010,459View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.0010,000View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.0056,000View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.0042,022View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.0058,000View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.003,000View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00175,818View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68313,797View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.004,459View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.0042,660View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.0052,022View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.004,459View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.0010,000View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.004,459View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00133,000View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00133,000View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00133,000View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.0042,660View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.0042,660View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00459View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.0061,000View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.0061,000View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00459View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.0061,000View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.0061,000View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Masimo (NASDAQ MASI) News Headlines

Source:
DateHeadline
Masimo Co. (MASI) Given Consensus Recommendation of "Hold" by AnalystsMasimo Co. (MASI) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - January 23 at 3:46 AM
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients - Business Wire (press release)New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients - Business Wire (press release)
www.businesswire.com - January 22 at 7:46 AM
6 Companies Growing Revenue and Earnings6 Companies Growing Revenue and Earnings
finance.yahoo.com - January 17 at 5:19 PM
President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology SummitPresident Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit
www.businesswire.com - January 17 at 9:31 AM
Masimo Gets FDA Nod for Rad-97, Enables Healthcare at Home ... - NasdaqMasimo Gets FDA Nod for Rad-97, Enables Healthcare at Home ... - Nasdaq
www.nasdaq.com - January 12 at 5:00 PM
Masimo Corp. (MASI) Announces FDA Clearance for Home Use of Rad-97Masimo Corp. (MASI) Announces FDA Clearance for Home Use of Rad-97
www.streetinsider.com - January 10 at 9:45 AM
Masimo Announces FDA Clearance for Home Use of Rad-97™Masimo Announces FDA Clearance for Home Use of Rad-97™
finance.yahoo.com - January 9 at 9:40 AM
Yongsam Lee Sells 10,000 Shares of Masimo Co. (MASI) StockYongsam Lee Sells 10,000 Shares of Masimo Co. (MASI) Stock
www.americanbankingnews.com - January 8 at 6:50 PM
Zacks: Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 EPSZacks: Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 EPS
www.americanbankingnews.com - January 6 at 5:10 PM
ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs MonitorZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
www.businesswire.com - January 5 at 4:57 PM
Masimo to Present at 36th Annual J.P. Morgan Healthcare ConferenceMasimo to Present at 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 5:13 PM
Masimo (MASI) Stock Rating Lowered by Zacks Investment ResearchMasimo (MASI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 3 at 10:18 AM
Robust Pipeline Aids Edwards Lifesciences, Rising Costs AilRobust Pipeline Aids Edwards Lifesciences, Rising Costs Ail
finance.yahoo.com - December 29 at 10:12 AM
Masimo Co. (MASI) Receives Consensus Rating of "Hold" from AnalystsMasimo Co. (MASI) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - December 29 at 4:28 AM
ETFs with exposure to Masimo Corp. : December 27, 2017ETFs with exposure to Masimo Corp. : December 27, 2017
finance.yahoo.com - December 28 at 8:32 AM
$201.63 Million in Sales Expected for Masimo Co. (MASI) This Quarter$201.63 Million in Sales Expected for Masimo Co. (MASI) This Quarter
www.americanbankingnews.com - December 23 at 8:30 AM
 Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 Earnings Per Share Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 Earnings Per Share
www.americanbankingnews.com - December 21 at 11:24 AM
Masimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : December 18, 2017Masimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : December 18, 2017
finance.yahoo.com - December 18 at 9:59 AM
ETFs with exposure to Masimo Corp. : December 14, 2017ETFs with exposure to Masimo Corp. : December 14, 2017
finance.yahoo.com - December 14 at 5:43 PM
Masimo Corp. – Value Analysis (NASDAQ:MASI) : December 12, 2017Masimo Corp. – Value Analysis (NASDAQ:MASI) : December 12, 2017
finance.yahoo.com - December 12 at 5:36 PM
Masimo (MASI) Downgraded to "Sell" at BidaskClubMasimo (MASI) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - December 9 at 1:38 PM
Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : December 8, 2017Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : December 8, 2017
finance.yahoo.com - December 8 at 9:40 AM
Free Research Report as Masimo’s Revenue Jumped 15.6%; EPS Surged 35%Free Research Report as Masimo’s Revenue Jumped 15.6%; EPS Surged 35%
finance.yahoo.com - December 8 at 9:40 AM
Masimo Co. (MASI) Expected to Announce Quarterly Sales of $201.63 MillionMasimo Co. (MASI) Expected to Announce Quarterly Sales of $201.63 Million
www.americanbankingnews.com - December 5 at 6:48 AM
Insider Selling: Masimo Co. (MASI) EVP Sells 5,900 Shares of StockInsider Selling: Masimo Co. (MASI) EVP Sells 5,900 Shares of Stock
www.americanbankingnews.com - December 4 at 9:02 PM
Masimo Co. (MASI) EVP Sells $1,616,892.30 in StockMasimo Co. (MASI) EVP Sells $1,616,892.30 in Stock
www.americanbankingnews.com - December 4 at 8:38 PM
Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas - Business Wire (press release)Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas - Business Wire (press release)
www.businesswire.com - December 3 at 5:11 PM
Masimo Corp. (MASI) Reports FDA Clearance and Worldwide Release of NomoLine Capnography Sampling LinesMasimo Corp. (MASI) Reports FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines
www.streetinsider.com - November 27 at 5:01 PM
Masimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling LinesMasimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling Lines
finance.yahoo.com - November 27 at 5:01 PM
5 MedTech Stocks to Beat Tax Hazards With Positive Returns5 MedTech Stocks to Beat Tax Hazards With Positive Returns
finance.yahoo.com - November 27 at 5:01 PM
Heres Why You Should Invest in Masimo (MASI) Right Now - NasdaqHere's Why You Should Invest in Masimo (MASI) Right Now - Nasdaq
www.nasdaq.com - November 24 at 5:17 PM
 Analysts Expect Masimo Corporation (MASI) Will Post Quarterly Sales of $201.63 Million Analysts Expect Masimo Corporation (MASI) Will Post Quarterly Sales of $201.63 Million
www.americanbankingnews.com - November 17 at 3:52 PM
ETFs with exposure to Masimo Corp. : November 17, 2017ETFs with exposure to Masimo Corp. : November 17, 2017
finance.yahoo.com - November 17 at 2:53 PM
Masimo Corporations (MASI) Stifel 2017 Healthcare Brokers Conference (Transcript)Masimo Corporation's (MASI) Stifel 2017 Healthcare Brokers Conference (Transcript)
seekingalpha.com - November 15 at 6:13 AM
Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : November 14, 2017Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : November 14, 2017
finance.yahoo.com - November 15 at 6:13 AM
Masimo Corporation (MASI) Expected to Announce Earnings of $0.61 Per ShareMasimo Corporation (MASI) Expected to Announce Earnings of $0.61 Per Share
www.americanbankingnews.com - November 15 at 3:24 AM
Masimo Supports World Pneumonia Day EffortsMasimo Supports World Pneumonia Day Efforts
finance.yahoo.com - November 14 at 3:01 AM
Masimo Corporation (MASI) EVP Yongsam Lee Sells 13,976 SharesMasimo Corporation (MASI) EVP Yongsam Lee Sells 13,976 Shares
www.americanbankingnews.com - November 10 at 12:20 AM
Masimo Corporation (MASI) Receives Average Rating of "Hold" from BrokeragesMasimo Corporation (MASI) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 9 at 3:38 AM
Masimo Announces Distribution of Rad-57® Pulse CO-Oximeters® by The Jeffrey Lee Williams Foundation to First RespondersMasimo Announces Distribution of Rad-57® Pulse CO-Oximeters® by The Jeffrey Lee Williams Foundation to First Responders
finance.yahoo.com - November 8 at 4:50 PM
Masimo to Present at Stifel 2017 Healthcare ConferenceMasimo to Present at Stifel 2017 Healthcare Conference
finance.yahoo.com - November 8 at 4:50 PM
Masimo Earns IBD Rating UpgradeMasimo Earns IBD Rating Upgrade
finance.yahoo.com - November 8 at 4:50 PM
Earnings Review and Free Research Report: NuVasive’s Q3 Non-GAAP EPS Surged 30% Y-o-Y; Surprised ExpectationsEarnings Review and Free Research Report: NuVasive’s Q3 Non-GAAP EPS Surged 30% Y-o-Y; Surprised Expectations
finance.yahoo.com - November 8 at 4:50 PM
ETFs with exposure to Masimo Corp. : November 6, 2017ETFs with exposure to Masimo Corp. : November 6, 2017
finance.yahoo.com - November 7 at 6:40 AM
Masimo Corporation (MASI) Expected to Post FY2019 Earnings of $3.12 Per ShareMasimo Corporation (MASI) Expected to Post FY2019 Earnings of $3.12 Per Share
www.americanbankingnews.com - November 6 at 2:20 PM
Stifel Nicolaus Reiterates "Buy" Rating for Masimo Corporation (MASI)Stifel Nicolaus Reiterates "Buy" Rating for Masimo Corporation (MASI)
www.americanbankingnews.com - November 3 at 6:32 PM
Masimo Corporation (MASI) EVP Sells $449,450.00 in StockMasimo Corporation (MASI) EVP Sells $449,450.00 in Stock
www.americanbankingnews.com - November 3 at 5:42 PM
Steven Barker Sells 10,000 Shares of Masimo Corporation (MASI) StockSteven Barker Sells 10,000 Shares of Masimo Corporation (MASI) Stock
www.americanbankingnews.com - November 3 at 5:26 PM
Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : November 3, 2017Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : November 3, 2017
finance.yahoo.com - November 3 at 4:25 PM
Masimo Corp. :MASI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017Masimo Corp. :MASI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
finance.yahoo.com - November 3 at 4:25 PM

SEC Filings

Masimo (NASDAQ:MASI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Masimo (NASDAQ:MASI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Masimo (NASDAQ MASI) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.